The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Nobivac Tricat Trio, lyophilisate and solvent for suspension for injection, for cats

. Lyophilisate and solvent for suspension for injection

Intervet Ireland LimitedVPA10996/204/001

Main Information

Trade NameNobivac Tricat Trio, lyophilisate and solvent for suspension for injection, for cats
Active SubstancesFeline calicivrus, strain f9 live attenuated
Feline herpes virus type 1, strain g2620a live attenuated
Feline panleucopenia virus, strain mw-1 live attenuated
Strength.
Dosage FormLyophilisate and solvent for suspension for injection
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/204/001

Group Information

ATC CodeQI06AD04 feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus
Therapeutic ClassImmunological - Live Vaccine
SpeciesCats

Status

Authorised/WithdrawnAuthorised
Licence Issued28/02/2007
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back